You are here: Home / Public / News


Submit your pre-proposals for European Innovative Research & Technological Development Projects in Nanomedicine till January 16th, 2018 (17:00, CET)!
Nanomedicine Award 2017 - Recipients
The European Technology Platform on Nanomedicine (ETPN) and ENATRANS announced the 2 recipients of the Nanomedicine Award 2017
Open call for innovative projects in personalised healthcare
The EU-funded INNOLABS project will select more than 100 innovative project ideas to accelerate and further support both financially and with services. Final submission deadline: 30 September 2017.
Find Nanomedicine related videos on ENATRANS YouTube Channel
ENATRANS compiles videos, animated movies and recordings of inspiring talks in its YouTube Channel with a particular focus on Nanomedicine Translation.
6th Round of applications to the NanomedTAB is open
The Nanomedicine Translation Advisory Board (nanomedTAB) offers since 2015 a free-of-charge mentoring program to assess, advise and accelerate promising nanomedicine projects to the market, based on a team of top skills industry experts with diverse and complementary experience. The objective? Help all projects and teams to get to clinical and commercial application faster and more reliably.
Nanomedicine Translation around the globe - How to proper address regulatory processes for nanomedicines in different countries
Nanomedicine Award 2017: applications are now open!
The European Technology Platform for Nanomedicine (ETPN) and the EU-funded project ENATRANS, announce the launching of the 3rd edition of the Nanomedicine Award, which aims to promote and reward two excellent innovative nanomedicine-based solutions that could bring significant benefits to patients, answering thereby unmet medical needs. The winners in both categories will be announced and rewarded during the BIO-Europe conference in Berlin in November 2017. Apply Now!
First European Nanomed "Who's who"
The first "Who's who" dedicated to European SMEs in nanomedicine is about to go live!
EMA PRIME: an opportunity for the translation of Nanomedicine?
The European Medicines Agency (EMA) launched PRIME (PRIority MEdicines), a new scheme to enhance support for the development of medicines that target an unmet medical need. This voluntary scheme is based on enhanced interaction and early dialogue with developers of promising medicines, to optimise development plans and speed up evaluation so these medicines can reach patients earlier.
Interview of Dr. Klaus-Michael Weltring - Nanotechnology: a key to the future of medicine Interview
The COMPAMED Magazine interviewed the ENATRANS Partner Klaus-Michael Weltring to discuss about expectations, achievements, gaps and barriers for future medical products based on naotechnologies.
EU-NCL- First call for characterisation of injectable nanomedicines addressing cancer
The recently established European Nanomedicine Characterisation Laboratory (EU-NCL) aims at providing critical infrastructure and characterisation services that are needed to analyse physical and chemical attributes, in vitro biological properties, and in vivo characteristics of emerging nanomedicines ready for translation and clinical trials.
Filed under:

Logo disruptive medtalk

Nanomed Award 2017

Upcoming Events
NanoBio&Med2017 Nov 22, 2017 - Nov 24, 2017 — Barcelona (spain)
MicroNanoConference - MNC 2017 Dec 12, 2017 - Dec 13, 2017 — Amsterdam (The Netherlands)
Upcoming events…